{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T14:10:46Z","timestamp":1763820646236,"version":"3.45.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,22]]},"DOI":"10.7759\/cureus.97501","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T14:06:16Z","timestamp":1763820376000},"source":"Crossref","is-referenced-by-count":0,"title":["Intracardiac Mass Reveals Hepatocellular Carcinoma: A Rare Case of Cardiac Metastasis"],"prefix":"10.7759","author":[{"given":"Tarig","family":"Abdelrahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anika","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harini","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afl084","article-title":"Falls in older people: epidemiology, risk factors and strategies for prevention","volume":"35","author":"Rubenstein LZ","year":"2006","unstructured":"Rubenstein LZ. Falls in older people: epidemiology, risk factors and strategies for prevention. Age Ageing. 2006, 35:ii37-ii41. 10.1093\/ageing\/afl084","journal-title":"Age Ageing"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0886","article-title":"A weak balance: the contribution of muscle weakness to postural instability and falls","volume":"4","author":"Horlings CG","year":"2008","unstructured":"Horlings CG, van Engelen BG, Allum JH, Bloem BR. A weak balance: the contribution of muscle weakness to postural instability and falls. Nat Clin Pract Neurol. 2008, 4:504-515. 10.1038\/ncpneuro0886","journal-title":"Nat Clin Pract Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v11.i1.1","article-title":"Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review","volume":"11","author":"Desai A","year":"2019","unstructured":"Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol. 2019, 11:1-18. 10.4254\/wjh.v11.i1.1","journal-title":"World J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000081333","article-title":"Hepatocellular carcinoma with intra-atrial tumor thrombi. A report of three cases responsive to thalidomide treatment and literature review","volume":"67","author":"Chang JY","year":"2004","unstructured":"Chang JY, Ka WS, Chao TY, Liu TW, Chuang TR, Chen LT. Hepatocellular carcinoma with intra-atrial tumor thrombi. A report of three cases responsive to thalidomide treatment and literature review. Oncology. 2004, 67:320-326. 10.1159\/000081333","journal-title":"Oncology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06036.x","article-title":"Clinical manifestations and survival of patients with hepatocellular carcinoma and cardiac metastasis","volume":"25","author":"Liu YC","year":"2010","unstructured":"Liu YC, Ho YL, Huang GT, Chen DS, Sheu JC, Chen CH. Clinical manifestations and survival of patients with hepatocellular carcinoma and cardiac metastasis. J Gastroenterol Hepatol. 2010, 25:150-155. 10.1111\/j.1440-1746.2009.06036.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6082-5_3","article-title":"Pathology of hepatocellular carcinoma","author":"Kojiro M","year":"2010","unstructured":"Kojiro M. Pathology of hepatocellular carcinoma. Molecular Genetics of Liver Neoplasia. 2010, 37-48. 10.1007\/978-1-4419-6082-5_3","journal-title":"Molecular Genetics of Liver Neoplasia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.06.031","article-title":"Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: a\u00a0systematic review and meta-analysis","volume":"45","author":"Chen ZH","year":"2019","unstructured":"Chen ZH, Zhang XP, Zhou TF, et al.. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: a\u00a0systematic review and meta-analysis. Eur J Surg Oncol. 2019, 45:2188-2196. 10.1016\/j.ejso.2019.06.031","journal-title":"Eur J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184422","article-title":"Surgical resection is superior to TACE in the treatment of HCC in a well selected cohort of BCLC-B elderly patients\u2014a retrospective observational study","volume":"14","author":"Brozzetti S","year":"2022","unstructured":"Brozzetti S, D'Alterio C, Bini S, et al.. Surgical resection is superior to TACE in the treatment of HCC in a well selected cohort of BCLC-B elderly patients\u2014a retrospective observational study. Cancers (Basel). 2022, 14:4422. 10.3390\/cancers14184422","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020468","article-title":"Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and non-viral hepatocarcinoma: pathophysiological mechanisms and new therapeutic strategies","volume":"11","author":"Vetrano E","year":"2023","unstructured":"Vetrano E, Rinaldi L, Mormone A, et al.. Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and non-viral hepatocarcinoma: pathophysiological mechanisms and new therapeutic strategies. Biomedicines. 2023, 11:468. 10.3390\/biomedicines11020468","journal-title":"Biomedicines"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9679-0","article-title":"Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis","volume":"10","author":"Mohamad B","year":"2016","unstructured":"Mohamad B, Shah V, Onyshchenko M, et al.. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Hepatol Int. 2016, 10:632-639. 10.1007\/s12072-015-9679-0","journal-title":"Hepatol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2014.10.003","article-title":"Systematic review of falls in older adults with cancer","volume":"6","author":"Wildes TM","year":"2015","unstructured":"Wildes TM, Dua P, Fowler SA, Miller JP, Carpenter CR, Avidan MS, Stark S. Systematic review of falls in older adults with cancer. J Geriatr Oncol. 2015, 6:70-83. 10.1016\/j.jgo.2014.10.003","journal-title":"J Geriatr Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05619-2","article-title":"Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment","volume":"29","author":"Sattar S","year":"2021","unstructured":"Sattar S, Haase K, Kuster S, et al.. Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment. Support Care Cancer. 2021, 29:21-33. 10.1007\/s00520-020-05619-2","journal-title":"Support Care Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001180","article-title":"Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus","volume":"127","author":"Scirica BM","year":"2013","unstructured":"Scirica BM. Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus. Circulation. 2013, 127:965-967. 10.1161\/CIRCULATIONAHA.113.001180","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-9001-3_28","article-title":"Role of environmental factors in increased cancer incidences and health impacts","author":"Khokhar A","year":"2022","unstructured":"Khokhar A, Sharma P. Role of environmental factors in increased cancer incidences and health impacts. Biotechnological Innovations for Environmental Bioremediation. Arora S, Kumar A, Ogita S, Yau YY (ed): Springer, Singapore; 2022. 671-723. 10.1007\/978-981-16-9001-3_28"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1142\/9781848161078_0009","article-title":"Oncogenes, tumor suppressors and co-factors in hepatocellular carcinoma","author":"Nagai H","year":"1998","unstructured":"Nagai H, Buendia MA. Oncogenes, tumor suppressors and co-factors in hepatocellular carcinoma. Hepatitis B Virus\u2014Molecular Mechanisms in Disease and Novel Strategies for Therapy. Koshy R, Wolfgang H (ed): Imperial College, London; 1998. 182-218. 10.1142\/9781848161078_0009"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-24-0686","article-title":"Liver cancer: progress and priorities","volume":"33","author":"McGlynn KA","year":"2024","unstructured":"McGlynn KA, Petrick JL, Groopman JD. Liver cancer: progress and priorities. Cancer Epidemiol Biomarkers Prev. 2024, 33:1261-1272. 10.1158\/1055-9965.EPI-24-0686","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29486","article-title":"Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: a systematic review and meta-analysis","volume":"67","author":"Finn RS","year":"2018","unstructured":"Finn RS, Zhu AX, Farah W, et al.. Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: a systematic review and meta-analysis. Hepatology. 2018, 67:422-435. 10.1002\/hep.29486","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v13.i11.1813","article-title":"Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: a systematic review","volume":"13","author":"Ahmed F","year":"2021","unstructured":"Ahmed F, Onwumeh-Okwundu J, Yukselen Z, et al.. Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: a systematic review. World J Gastrointest Oncol. 2021, 13:1813-1832. 10.4251\/wjgo.v13.i11.1813","journal-title":"World J Gastrointest Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221080298","article-title":"Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience","volume":"14","author":"de Castro T","year":"2022","unstructured":"de Castro T, Jochheim LS, Bathon M, et al.. Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience. Ther Adv Med Oncol. 2022, 14:17588359221080298. 10.1177\/17588359221080298","journal-title":"Ther Adv Med Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/394576-intracardiac-mass-reveals-hepatocellular-carcinoma-a-rare-case-of-cardiac-metastasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T14:06:17Z","timestamp":1763820377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/394576-intracardiac-mass-reveals-hepatocellular-carcinoma-a-rare-case-of-cardiac-metastasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.97501","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,22]]}}}